Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ray Bendele"'
Autor:
Ray Bendele, John Desjardins, Susan Karimi, Beth Abbott, Frank C. Richardson, Dennis J. Meyer, Greg Biesecker
Publikováno v:
Antiviral Research. 58:217-225
The antiviral compound tenofovir DF (Gilead Sciences) was evaluated for possible mitochondrial toxicity in rats, rhesus monkeys and woodchucks. Animals were treated by oral gavage with tenofovir DF, and the levels of mitochondrial enzymes cytochrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a69a40081accb82d119adc388ed3e692
https://doi.org/10.1016/s0166-3542(03)00005-6
https://doi.org/10.1016/s0166-3542(03)00005-6
Publikováno v:
Toxicologic Pathology. 27:22-26
The following material was derived from a synthesis of case histories taken from investigational new drug (IND) applications and drug sponsors' experiences, utilizing fictionalized data to avoid any resemblance to any proprietary information; any suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5cdb7b2c329bc9f679a2649ba2054a4
https://doi.org/10.1177/019262339902700105
https://doi.org/10.1177/019262339902700105
Autor:
Jeremy D. LeRay, Michelle Pelanne, Blake Tomkinson, Eric N. Brown, Karen Hart, David L. Emerson, Denny J. Meyer, Atherton G. Gray, Ray Bendele, Francis J. Giles
Publikováno v:
Leukemia research. 27(11)
OSI-211 (liposomal lurtotecan), was evaluated using several different dose schedules (1mg/kg, d1-5, 1.75 mg/kg d1, 3, 5 and 6 mg/kg d1, 8) in severe combined immunodeficient (SCID) mouse models of acute myelogenous leukemia (AML) and acute lymphocyti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc3a3467546d86d09a3724d591d3632
https://pubmed.ncbi.nlm.nih.gov/12859997
https://pubmed.ncbi.nlm.nih.gov/12859997
Autor:
Koen K. A. Van Rompay, Ross P. Tarara, Wilhelm Von Morgenland, Marta L. Marthas, Abigail Spinner, John Desjardins, David R. Bennett, Valerie F. Samii, Christopher Jerome, Alesha B. Castillo, Norbert Bischofberger, Dennis J. Meyer, Trish G. Dearman, Marta Hamilton, Niels C Pedersen, Celia R. Valverde, Phil C. Allen, R. Bruce Martin, Don R. Canfield, Linda Hirst, Laurie L. Brignolo, Ray Bendele
Publikováno v:
Antimicrobial Agents and Chemotherapy. 48:2346-2346
The reverse transcriptase inhibitor 9-[2-(phosphonomethoxy)propyl]adenine (PMPA; tenofovir) was previously found to offer strong prophylactic and therapeutic benefits in an infant macaque model of pediatric human immunodeficiency virus (HIV) infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a64c72ede76b2dd60f66f8f29256a95
https://doi.org/10.1128/aac.48.6.2346.2004
https://doi.org/10.1128/aac.48.6.2346.2004